Potential Role of Acupuncture Treatment in Neuronal and Network Dysfunction in Patients With Vascular Cognitive Impairment
NCT04087499, Not applicable, Unknown, Chang Gung Memorial Hospital
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Potential Role of Acupuncture Treatment in Neuronal and Network Dysfunction in Patients With Vascular Cognitive Impairment | ClinicalTrials.gov |
| NCT number | NCT04087499 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 80 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Chang Gung Memorial Hospital | ClinicalTrials.gov |
| Conditions | Vascular Cognitive Impairment | ClinicalTrials.gov |
| Interventions | Acupuncture | ClinicalTrials.gov |
| First posted | 2019-09-12 | ClinicalTrials.gov |
| Last updated | 2019-10-03 | ClinicalTrials.gov |
Registered outcomes 13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change from baseline sleep quality at 3 months, 6 months, 12 months | 3 months, 6 months, 12 months | Analogous variables were extracted from actigraphy. The sleep variables collected were sleep start time, sleep end time, sleep duration, sleep efficiency, and wake after sleep onset time, and the activity variables collected were heart rate activity score,activity amount, and activity intensity | ClinicalTrials.gov |
| Secondary | Change from baseline neuro-behavioral performances at 3 months, 6 months, 12 months | 3 months, 6 months, 12 months | Cognitive Abilities Screening Instrument (CASI). In addition to general cognitive performance, CASI was used to evaluate specific domains, including short-term memory, attention and concentration, abstraction, visual construction, language, and list-generating fluency. | ClinicalTrials.gov |
| Secondary | Change from baseline motor function (UPDRS) at 3 months, 6 months, 12 months | 3 months, 6 months, 12 months | Unified Parkinson's Disease Rating Scale (UPDRS)-part III scores for parkinsonian features. | ClinicalTrials.gov |
| Secondary | Change from baseline motor function (NIHSS) at 3 months, 6 months, 12 months | 3 months, 6 months, 12 months | NIH Stroke Scale (NIHSS) score 0-24. | ClinicalTrials.gov |
| Secondary | Change from baseline continuous motor function at 3 months, 6 months, 12 months | 3 months, 6 months, 12 months | Physical activity was measured using accelerometers. | ClinicalTrials.gov |
| Secondary | Change from baseline memory performances at 3 months, 6 months, 12 months | 3 months, 6 months, 12 months | Verbal memory were evaluated by using Chinese Version Verbal Learning Test (CVVLT).Visual-spatial abilities. | ClinicalTrials.gov |
| Secondary | Change from baseline executive performances at 3 months, 6 months, 12 months | 3 months, 6 months, 12 months | Attention and executive function was evaluated by Trail Making Test B. | ClinicalTrials.gov |
| Secondary | Change from baseline executive performances (Stroop interference test) at 3 months, 6 months, 12 months | 3 months, 6 months, 12 months | Attention and executive function was evaluated by Stroop interference test. | ClinicalTrials.gov |
| Secondary | Change from baseline executive performances (calculation) at 3 months, 6 months, 12 months | 3 months, 6 months, 12 months | As the calculation ability depends on executive function, calculation ability was evaluated to reflect part of executive function. | ClinicalTrials.gov |
| Secondary | Change from baseline abstract thinking at 3 months, 6 months, 12 months | 3 months, 6 months, 12 months | Abstract reasoning was evaluated by using similarities (conceptualization) in frontal assessment battery-Similarities. | ClinicalTrials.gov |
| Secondary | Change from baseline language performances at 3 months, 6 months, 12 months | 3 months, 6 months, 12 months | Boston Naming Test were used to evaluate language ability in naming. | ClinicalTrials.gov |
| Secondary | Change from baseline fluency performances at 3 months, 6 months, 12 months | 3 months, 6 months, 12 months | Semantic category fluency. | ClinicalTrials.gov |
| Secondary | Change from baseline neuropsychiatric symptoms at 3 months, 6 months, 12 months | 3 months, 6 months, 12 months | The neuropsychiatric symptoms of the participants were measured using the Neuropsychiatric Inventory. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 6
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Category Fluency | Secondary outcome | ConductCognition |
| Picture Naming Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
| Verbal Learning | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)